Expertise in
1
conditions

Peter Stalmans

UZLeuven
Leuven, VLG, BE 
Expertise in
1
conditions
UZLeuven
Leuven, VLG, BE 
OverviewLocationsClinical Research

Overview

Peter Stalmans practices in Leuven, Belgium. Mr. Stalmans is highly rated in 1 condition, according to our data. His top areas of expertise are Retinal Detachment, Endophthalmitis, Glaucoma, Ocular Hypertension (OHT), and Vitrectomy.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

UZLeuven
Leuven, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Safety and Performance Evaluation of the NR600 System in Subjects With End-stage Inherited Outer Retinal Degenerative Diseases
Safety and Performance Evaluation of the NR600 System in Subjects With End-stage Inherited Outer Retinal Degenerative Diseases
Enrollment Status: Terminated
Publish Date: March 15, 2023
Intervention Type: Device
Study Phase: Not Applicable
IRIS Alfa Clinical Trial. A Safety Study of a Prototype of a New Vitrectomy Device.
IRIS Alfa Clinical Trial. A Safety Study of a Prototype of a New Vitrectomy Device.
Enrollment Status: Terminated
Publish Date: November 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
Comparative Study 27G Vitrectomy vs Larger Gauge Surgery
Comparative Study 27G Vitrectomy vs Larger Gauge Surgery
Enrollment Status: Completed
Publish Date: July 11, 2022
Intervention Type: Device
Study Phase: Not Applicable
EVA Nexus Field Observation Study. A Monocentric, Academic Field Observation Study of a Prototype of a New CE-labeled Vitrectomy Device Developed by DORC BV (The Netherlands).
EVA Nexus Field Observation Study. A Monocentric, Academic Field Observation Study of a Prototype of a New CE-labeled Vitrectomy Device Developed by DORC BV (The Netherlands).
Enrollment Status: Completed
Publish Date: July 05, 2022
Intervention Type: Device
View 3 Less Clinical Trials

12 Total Publications

Pazopanib-induced bilateral rhegmatogenous retinal detachment treated with scleral buckling.
Pazopanib-induced bilateral rhegmatogenous retinal detachment treated with scleral buckling.
Journal: Retinal cases & brief reports
Published: October 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Stalmans's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile